Cardiovascular Inflammation Reduction Trial - Inflammation Imaging Study
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 123 participants.
Also called NCT02576067
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 123 participants
- Sponsor
- Registry
-
NCT02576067
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada
- Registry status
- Completed
Technical summary
Registry record NCT02576067. Randomized; double masking; primary purpose treatment. Start 2015-12-18 (actual); primary completion 2019-03-29 (actual). Results posted on 2020-04-20.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Cardiovascular Inflammation Reduction Trial - Inflammation Imaging Study
- Acronym
- CIRT
- Condition
- Vascular Inflammation
- Condition
- Atherosclerotic Cardiovascular Disease
- Intervention (Drug)
- Low dose methotrexate
- Intervention (Drug)
- Placebo
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Collaborator
- Brigham and Women's Hospital
- Collaborator
- Massachusetts General Hospital
- Collaborator
- Unity Health Toronto
- Collaborator
- National Institutes of Health (NIH)
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
Record details
- Record id
cardio:ct-nct02576067- Content hash
921376d7d97a2316b2f435d442a0391a94a4dec81cbf41218b7fd6e96823ae19